1) Hofmann GE, Toner JP, Muasher SJ, et al : High─dose follicle─stimulating hormone(FSH)ovarian stimulation in low─responder patients for in vitro fertilization. J In Vitro Fert Embryo Transf 6 : 285─289, 1989
2) Yong PY, Brett S, Baird DT, et al : A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle─stimulaing hormone(Gonal─F)in a fixed─dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril 79 : 308─315, 2003
3) Marrs R, Meldrum D, Muasher S, et al : Randomized trial to compare the effect of recombinant human FSH(follitroppin alpha)with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 8 : 175─182, 2004
4) Humaidan P, Bungum M, Bungum L, et al : Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down─regulation and stimulation with recombinant FSH : an opening study. Reprod Biomed Online 8 : 635─643, 2004
5) Ferraretti AP, Gianaroli L, Magli MC, et al : Exogenous lutenizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril 822 : 1521─1526, 2004
6) Chung K, Krey L, Katz J, et al : Evaluating the role of exogenous lutenizing hormone in poor responders undergoing in vitro fertilization with gonadotropin─releasing hormone antagonists. Fertil Steril 84 : 313─318, 2005
7) Fabregues F, Creus M, Penarrubia J, et al : Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation rate in down─regulated women of advanced reproductive age. Fertil Steril 85 : 925─931, 2006
8) Loutradis D, Elsheikh A, Kallianidis K, et al : Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations. Arch Gynecol Obstet 270 : 223─226, 2004
9) 杉本公平,他 : 高齢不妊患者の体外受精周期における排卵誘発法の検討.日受精着床会誌21 : 160─162, 2004
10) Feldberg D, Farhi J, Ashkenazi J, et al : Minidose gonadotropin─releasing hormone agonist in the treatment of chice in poor responders with high follicle─stimulating hormone levels. Fertil Steril 62 : 343─346, 1994
11) D’Amato G, Caroppo E, Pasquadibisceglie A, et al : A novel protocol of ovulation induction with delayed gonadotropin─releasing hormone antagonist administration combined with higjh─dose recombinant follicle─stimulating hormone and clomiphen citrate for poor responders and women over 35 years. Fertil Steril 81 : 1572─1577, 2004
12) Gleicher N, Vietzke M, Vidali A : Bye─bye urinary gonadotrophins? Recombinant FSH : A real progress in ovulation induction in IVF? Hum Reprod 18 : 476─482, 2003
13) Lindheim SR, Barad DH, Zinger M, et al : Short─term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet 13 : 745─747, 1996
14) Olivennes F, Belaisch─Allart J, Emperaire JC, et al : Prospective, randomized, controlled study of in vitro fertilization─embryo transfer with a single dose of a lutenizing hormone─releasing hormone(LH─RH)antagonist(cetrorelix)or a depot formula of an LH─RH agonist(triptorelin). Fertil Steril 73 : 314─320, 2000
15) Albano C, Felberbaum RE, Smitz J, et al : Ovarian stimulation with HMG : results of a prospective randomized phaseIIIEuropean study comparing the lutenizing hormone─releasing hormone(LH─RH)─ antagonist cetrorelix and the LH─RH agonist buserelin. Hum Reprod 15 : 526─531, 2000
16) Lord JM, Flight IHK, Norman RJ : Metformin in polycystic ovary syndrome : systematic review and meta─analysisi. BMJ 327 : 951─956, 2003
17) Costello MF, Chapman M, Conway U : A systematic review and meta─analysis of randomized controlled trials on Metoformin co─administration during gonadotrophin ovulation induction or IVF in women with polycytic ovary syndrome. Hum Reprod 21 : 1387─1399, 2006
18) 倉林 工 : 生殖医療ガイドライン2007(日本生殖医学会編).pp191─192,金原出版,2007